Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 7, 2014; 20(33): 11574-11585
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11574
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11574
miRNA | Level of expression | Clinical application | Ref. |
miR-301a | Up-regulated | Progression and prognostic | [127] |
miR-29 family | Down-regulated | Prognostic and therapeutic | [128] |
miR-146a | Down-regulated | Metastasis | [129] |
miR-10b | Up-regulated | Progression and prognostic | [130] |
miR-107 | Up-regulated | Prognostic | [131] |
miR-345 + miR-142 | Up-regulated (miR-345) and Down-regulated (miR-142) | Recurrence and progression | [132] |
let-7i | Down-regulated | Prognostic and therapeutic | [133] |
miR-221 | Up-regulated | Progression, prognostic and therapeutic | [125,134] |
miR-148a | Down-regulated | Prognostic | [135] |
miR-155 | Down-regulated | Progression and metastasis | [136] |
miR-129-2-3p | Down-regulated | Progression | [137] |
miR-181b | Up-regulated | Prognostic | [138] |
miR-21 | Up-regulated | Prognostic | [138,139] |
- Citation: Pinheiro DDR, Ferreira WAS, Barros MBL, Araújo MD, Rodrigues-Antunes S, Borges BDN. Perspectives on new biomarkers in gastric cancer: Diagnostic and prognostic applications. World J Gastroenterol 2014; 20(33): 11574-11585
- URL: https://www.wjgnet.com/1007-9327/full/v20/i33/11574.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i33.11574